theobromine has been researched along with Arteriosclerosis Obliterans in 10 studies
Theobromine: 3,7-Dimethylxanthine. The principle alkaloid in Theobroma cacao (the cacao bean) and other plants. A xanthine alkaloid that is used as a bronchodilator and as a vasodilator. It has a weaker diuretic activity than THEOPHYLLINE and is also a less powerful stimulant of smooth muscle. It has practically no stimulant effect on the central nervous system. It was formerly used as a diuretic and in the treatment of angina pectoris and hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, pp1318-9)
theobromine : A dimethylxanthine having the two methyl groups located at positions 3 and 7. A purine alkaloid derived from the cacao plant, it is found in chocolate, as well as in a number of other foods, and is a vasodilator, diuretic and heart stimulator.
Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A study was carried out in 17 patients with arteriosclerosis obliterans to assess the effectiveness of treatment with pentoxifylline ('Trental') and to investigate its possible mechanism of action." | 9.05 | Beneficial results of pentoxifylline ('Trental') therapy in arteriosclerosis obliterans: possible mechanism of action. ( Bieroń, K; Dembińska-Kieć, A; Grodzińska, L; Gryglewski, RJ; Kostka-Trabkowa, E, 1985) |
| "A study was carried out in 17 patients with arteriosclerosis obliterans to assess the effectiveness of treatment with pentoxifylline ('Trental') and to investigate its possible mechanism of action." | 5.05 | Beneficial results of pentoxifylline ('Trental') therapy in arteriosclerosis obliterans: possible mechanism of action. ( Bieroń, K; Dembińska-Kieć, A; Grodzińska, L; Gryglewski, RJ; Kostka-Trabkowa, E, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strano, A | 1 |
| Davì, G | 1 |
| Novo, S | 1 |
| Avellone, G | 1 |
| Pinto, A | 1 |
| Cavaller, JM | 1 |
| Samper, JC | 1 |
| Chyzy, R | 1 |
| Lukjan, H | 1 |
| Rość, D | 1 |
| Bielawiec, M | 1 |
| Sawicka, J | 1 |
| Beykirch, H | 1 |
| Reuter, W | 1 |
| Voigt, H | 1 |
| Herrmann, W | 1 |
| Poggesi, L | 1 |
| Boddi, M | 1 |
| Scarti, L | 1 |
| Masotti, G | 1 |
| Di Perri, T | 1 |
| Kuczyńska, K | 1 |
| Zebrowski, M | 2 |
| Kancelarczyk, WL | 2 |
| Rymaszewski, Z | 1 |
| Berent, H | 1 |
| Uchman, B | 1 |
| Atroshchenko, ES | 1 |
| Kostka-Trabkowa, E | 1 |
| Dembińska-Kieć, A | 1 |
| Grodzińska, L | 1 |
| Bieroń, K | 1 |
| Gryglewski, RJ | 1 |
1 review available for theobromine and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
[Treatment of vascular diseases of the extremities using pentoxifylline].
Topics: Aminophylline; Arteriosclerosis Obliterans; Clinical Trials as Topic; Drug Evaluation; Humans; Inter | 1988 |
4 trials available for theobromine and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
[Use of pentoxifylline (BL 191) in the treatment of peripheral blood circulation disorders].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Clinical Trials as Topic; Drug Evaluation; Female; Humans; | 1976 |
[Treatment of vascular diseases of the extremities using pentoxifylline].
Topics: Aminophylline; Arteriosclerosis Obliterans; Clinical Trials as Topic; Drug Evaluation; Humans; Inter | 1988 |
[Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Clinical Trials as Topic; Humans; Hypolipidemic Agents; Le | 1988 |
Beneficial results of pentoxifylline ('Trental') therapy in arteriosclerosis obliterans: possible mechanism of action.
Topics: Adenosine Diphosphate; Adult; Aged; Arteriosclerosis Obliterans; Blood Coagulation Tests; Clinical T | 1985 |
6 other studies available for theobromine and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
[Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
Topics: Aged; Arteriosclerosis Obliterans; Blood Pressure; Blood Viscosity; Brain Ischemia; Drug Evaluation; | 1981 |
Some haemorheological factors in patients with arteriosclerosis obliterans after treatment of trental.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Arteriosclerosis Obliterans; Cyclic AMP; Erythrocyte Deformabili | 1987 |
[Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline].
Topics: Arteriosclerosis Obliterans; Hemodynamics; Humans; Ischemia; Leg; Lipids; Male; Middle Aged; Nifedip | 1989 |
[Pentoxifylline and prostaglandins].
Topics: 6-Ketoprostaglandin F1 alpha; Arteriosclerosis Obliterans; Blood Platelets; Cyclic AMP; Endothelium, | 1988 |
[Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Leg | 1988 |
[Use of pentoxifylline (trental) to correct microcirculatory disorders in patients with atherosclerosis of peripheral arteries].
Topics: Adult; Arteriosclerosis Obliterans; Cardiac Output; Hemodynamics; Humans; Iodine Radioisotopes; Male | 1986 |